Nauck MA, Vilsbll T, Gallwitz B, Garber A, Madsbad S (2009) Incretin-based therapies
They can also disrupt signaling from brain-gut hormones, like adiponectin and leptin and ghrelin, which are supposed to tell you, Stop eating, were done, were full. Disruption of that signaling pathway can be a potential complication
EMA/CHMP/700447/2022
Look for compounded versions that include glycine, which can reduce irritation by balancing the pH of the injection
Int J Mol Sci 16:2236822401 Duda P, Wisniewski J, Wojtowicz T, Wojcicka O, Jaskiewicz M, Drulis-Fajdasz D, Rakus D, McCubrey JA, Gizak A (2018) Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Category strategy is in full focus as the behavior of GLP-1 users becomes more clear, with brands in the right spaces already seeing significant volume gains